If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Fabio De Vincenzo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Pemetrexed Medicine & Life Sciences
Castration Medicine & Life Sciences
Prostatic Neoplasms Medicine & Life Sciences
Retrospective Studies Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Cohort Studies Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Cisplatin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2005 2019

Ligands
Carcinoma
Lung
Therapeutics
anaplastic lymphoma kinase

Phase II study of everolimus in patients with thymoma and thymic carcinoma previously treated with cisplatin-based chemotherapy

Zucali, P. A., De Pas, T., Palmieri, G., Favaretto, A., Chella, A., Tiseo, M., Caruso, M., Simonelli, M., Perrino, M., De Vincenzo, F., Toffalorio, F., Damiano, V., Pasello, G., Garbella, E., Ali, M., Conforti, F., Ottaviano, M., Cioffi, A., De Placido, S., Giordano, L. & 4 others, Bertossi, M., Destro, A., Di Tommaso, L. & Santoro, A., Feb 1 2018, In : Journal of Clinical Oncology. 36, 4, p. 342-349 8 p.

Research output: Contribution to journalArticle

Thymoma
Cisplatin
Drug Therapy
Everolimus
Disease-Free Survival

Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Cisplatin-Based Chemotherapy

Zucali, P. A., De Pas, T., Palmieri, G., Favaretto, A., Chella, A., Tiseo, M., Caruso, M., Simonelli, M., Perrino, M., De Vincenzo, F., Toffalorio, F., Damiano, V., Pasello, G., Garbella, E., Ali, M., Conforti, F., Ottaviano, M., Cioffi, A., De Placido, S., Giordano, L. & 4 others, Bertossi, M., Destro, A., Di Tommaso, L. & Santoro, A., Feb 1 2018, In : Journal of Clinical Oncology. 36, 4, p. 342-349 8 p.

Research output: Contribution to journalArticle

Thymoma
Cisplatin
Drug Therapy
Everolimus
Disease-Free Survival

Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Cisplatin-Based Chemotherapy

Zucali, P. A., De Pas, T., Palmieri, G., Favaretto, A., Chella, A., Tiseo, M., Caruso, M., Simonelli, M., Perrino, M., De Vincenzo, F., Toffalorio, F., Damiano, V., Pasello, G., Garbella, E., Ali, M., Conforti, F., Ottaviano, M., Cioffi, A., De Placido, S., Giordano, L. & 4 others, Bertossi, M., Destro, A., Di Tommaso, L. & Santoro, A., Feb 1 2018, In : Journal of Clinical Oncology. 36, 4, p. 342-349 8 p.

Research output: Contribution to journalArticle

Thymoma
Cisplatin
Drug Therapy
Everolimus
Disease-Free Survival
Pemetrexed
Fluorodeoxyglucose F18
Positron-Emission Tomography
Pleurodesis
Glycolysis